Master Validation Planning and Tougher U.S. FDA & MDD Mod 5

Instructor: John E Lincoln
Product ID: 701629
Training Level: Intermediate to Advanced
  • Duration: 84 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: Apr-2010

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

This Master Validation Planning training will evaluate how to do Validation and Verification under the current changes came due to the March 2010 Mod 5 changes to the EU MDD.

Why Should You Attend:
Both the U.S. FDA and the EU's MDD require companies to be proactive in reducing product risk while increasing user benefits. But following questions comes in to picture

  • Once the product and process design activities develop new or substantially changed products, how can these be verified and validated?
  • Company and submission data must be more "science based". Recalls point to serious V&V shortfalls. How can these be addressed?
  • What V&V planning steps are expected under the CGMPs.
  • How can these consistently be executed at all plant sites?
  • Where does ISO 14971, ICH Q9, and similar risk management systems come in? Across industries?
  • How does the March 2010 Mod 5 changes to the EU MDD impact product validation planning?

This webinar will evaluate the climate that has resulted in this call for change, and flag areas for heightened compliance in V&V planning. It will focus on eliminating such negative "triggers", reduce "fire fighting" and identify, minimize or eliminate major systemic validation problems. It will assist the attendee to review their existing system in light of current and anticipated changes in regulatory thinking, and in approaches to implementing necessary changes.

Areas Covered in the Seminar:

  • Tougher FDA V&V Expectations.
  • Key Product V&V Requirements.
  • Key Equipment, Process, Software and QMS / Part 11 V&V Activities.
  • Growing Problem Areas.
  • The EU's MDD Mod 5 Changes and V&V Planning / Documentation.
  • How to Implement, Execute and Document.
  • Allocation of Scarce Resources.

Who Will Benefit:

This webinar will provide valuable assistance to personnel in all regulated companies responsible for cGMP and MDD/CE-mark compliance. This information applies to primarily to personnel / companies in the Medical Device industry. However, its principles apply and can be used in other regulated industries, e.g., Pharmaceutical, Diagnostic, Biologics and Dietary Supplements. The employees who will benefit include:
  • Senior management
  • Regulatory Affairs
  • Quality Assurance
  • Production
  • Engineering
  • Sales and Marketing
  • All personnel involved in a U.S. FDA- and/or EU ISO 13485/MDD-regulated environment

Instructor Profile:
John E. Lincoln, is Principal of J. E. Lincoln and Associates, a consulting company with over 28 years experience in U.S. FDA-regulated industries. John has worked with companies from start-up o Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D).

In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, conducted workshops and webinars worldwide on CAPA, 510(k)s, risk analysis / management, FDA / GMP audits, validation, root cause analysis, and others. John is a graduate of UCLA.

Follow us :
Seminars by Ex-FDA Officials
Upcoming In-person Seminars by EX-FDA OFFICIALS

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed